Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “Paranoid Disorders”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 235 records · Page 13Linked to original sources
PubMed1976

Comparison of differential diagnostic discrimination for abbreviated and standard MMPI.

MMPI response protocols for 194 psychiatric patients were scored on the basis of the first 168 items and then on the usual 400 items. The MMPI-168 raw scores were converted to estimates of conventional clinical scale scores. The Ss were divided into 10 major categories on the basis of final clinical diagnosis. Multiple discriminant analysis was used to compare the discriminant validity of the abbreviated and standard scoring. The results indicated no loss in discrimination to result from scoring based on only the first 168 items. Conversion tables that can be used to transform MMPI-168 raw scores to standard MMPI clinical scale scores are presented for further research and clinical use.

Acute Disease↗
PubMed1989

The MCMI-II as a treatment outcome measure for psychiatric inpatients.

Recently, the MCMI-II (Millon, 1987) has been introduced as a successor to the MCMI-I (Millon, 1983). This study evaluated the MCMI-II as a treatment outcome measure for psychiatric inpatients. Ninety-eight patients were tested at admission and discharge with the MCMI-II. Changes in mean MCMI-II scores on the basic and pathological personality scales, as well as the moderate and severe symptom scales, were generally congruent with findings from a previous outcome study with the MCMI-I (Piersma, 1986a). However, several differences between the MCMI-II and MCMI-I were noted, which suggests that the MCMI-II will need to be cross-validated as an instrument distinct from the MCMI-I.

Adult↗
PubMed1988

Psychiatric side effects during the treatment of Parkinson's disease.

Dopaminergic agents including both levodopa and direct-acting agonists induce a variety psychiatric side-effects of which psychosis is the most significant. When this occurs early in the course of treatment, there is usually a history of prior psychotic illness. Chronic treatment can, however, elicit psychosis in individuals without such a history. The possible pathogenesis of this is reviewed.

Dreams↗